ZA47 Pill: white, capsule/oblong, 18mm
The pill with imprint ZA47 (White, Capsule/Oblong, 18mm) has been identified as Divalproex Sodium Extended-Release 250 mg and is used for Bipolar Disorder, Mania, Migraine Prevention, Seizures, and Epilepsy. It belongs to the drug class fatty acid derivative anticonvulsants and is not a controlled substance.
Images for ZA47
Divalproex Sodium Extended-Release
- Imprint
- ZA47
- Strength
- 250 mg
- Color
- White
- Size
- 18.00 mm
- Shape
- Capsule/Oblong
- Availability
- Prescription only
- Drug Class
- Fatty acid derivative anticonvulsants
- Pregnancy Category
- D - Positive evidence of risk - When treating epilepsy and manic episodes associated with bipolar disorder, X - Not for use in pregnancy - When treating migraine
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- BluePoint Laboratories
- Inactive Ingredients
-
hydroxypropyl cellulose,
hypromelloses,
soya lecithin,
magnesium stearate,
polyethylene glycol,
polyvinyl alcohol,
silicon dioxide,
magnesium silicate,
titanium dioxide,
xanthan gum
Note: Inactive ingredients may vary.
Labelers / Repackagers
| NDC Code | Labeler / Repackager |
|---|---|
| 68001-0105 | |
| 68084-0310 | Amerisource Health Services |
See also:
More about divalproex sodium
- Check interactions
- Compare alternatives
- Pricing & coupons
- Reviews (514)
- Drug images
- Side effects
- Dosage information
- Patient tips
- During pregnancy
- Drug class: fatty acid derivative anticonvulsants
- Breastfeeding
- En español
Patient resources
Other brands
Depakote, Depakote ER, Depakote Sprinkles
Professional resources
- Divalproex Capsules prescribing information
- Divalproex Delayed Release (FDA)
- Divalproex Delayed Release Tablets (FDA)
- Divalproex Extended Release (FDA)
- Divalproex Sprinkle (FDA)
Other brands
Depakote, Depakote ER, Depakote Sprinkles
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.